- Home
- NRXS vs TPCS Comparison
NRXS vs TPCS Comparison
Compare NRXS & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRXS | TPCS |
|---|---|---|
| Founded | 2011 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Metal Fabrications |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.3M | 40.9M |
| IPO Year | 2023 | 2008 |
Fundamental Metrics
Financial Performance| Metric | NRXS | TPCS |
|---|---|---|
| Price | $6.26 | $3.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 113.9K | 43.2K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.89 | 64.20 |
| EPS | N/A | ★ N/A |
| Revenue | $2,685,925.00 | ★ $34,031,000.00 |
| Revenue This Year | $31.05 | N/A |
| Revenue Next Year | $146.31 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 9.18 | 7.72 |
| 52 Week Low | $1.33 | $2.08 |
| 52 Week High | $6.35 | $6.25 |
Technical Indicators
Market Signals| Indicator | NRXS | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 64.37 | 31.58 |
| Support Level | $2.32 | $3.67 |
| Resistance Level | $6.20 | $3.85 |
| Average True Range (ATR) | 0.46 | 0.16 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 76.00 | 34.48 |
Price Performance
Historical ComparisonAbout NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About TPCS TechPrecision Corporation
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.